Alizyme is a drug development company dedicated to providing treatments for … irritable bowel syndrome, inflammatory Bow disease, obesity, diabetes, and mucositis. A disease that affects millions of people worldwide. Our goal is to deliver new and improved medicines to the people who suffer from these diseases.
| Products in development | |||
 | | COLAL-PRED | Inflammatory bowel disease; IBD |
| | Renzapride | Irritable bowel syndrome; IBS |
| | ATL-962 | Obesity / Diabetes |
| | ATL-104 | Mucositis |
| | COLAL | Colonic-specific drug delivery |